158 related articles for article (PubMed ID: 34377159)
21. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
[TBL] [Abstract][Full Text] [Related]
22. Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs.
Wong SCT; Li IWS; Ng AHY; Lau CS; Chung HY
Int J Rheum Dis; 2020 Feb; 23(2):189-196. PubMed ID: 31489783
[TBL] [Abstract][Full Text] [Related]
23. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes.
Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150
[TBL] [Abstract][Full Text] [Related]
24. Elevated Lp(a) (Lipoprotein[a]) Levels Increase Risk of 30-Day Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy.
Waissi F; Dekker M; Timmerman N; Hoogeveen RM; van Bennekom J; Dzobo KE; Schnitzler JG; Pasterkamp G; Grobbee DE; de Borst GJ; Stroes ESG; de Kleijn DPV; Kroon J
Stroke; 2020 Oct; 51(10):2972-2982. PubMed ID: 32878565
[TBL] [Abstract][Full Text] [Related]
25. Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs.
Atzeni F; Carletto A; Foti R; Sebastiani M; Panetta V; Salaffi F; Bonitta G; Iannone F; Gremese E; Govoni M; Marchesoni A; Favalli EG; Gorla R; Ramonda R; Sarzi-Puttini P; Ferraccioli G; Lapadula G;
Joint Bone Spine; 2018 Jul; 85(4):455-459. PubMed ID: 28893679
[TBL] [Abstract][Full Text] [Related]
26. Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis.
Favalli EG; Selmi C; Becciolini A; Biggioggero M; Ariani A; Santilli D; Fusaro E; Parisi S; Massarotti M; Marchesoni A; Meroni PL
Arthritis Care Res (Hoboken); 2017 Jun; 69(6):867-874. PubMed ID: 27696735
[TBL] [Abstract][Full Text] [Related]
27. Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet database.
Scirè CA; Caporali R; Sarzi-Puttini P; Frediani B; Di Franco M; Tincani A; Sinigaglia L; Sfriso P; Tirri R; Bellis E; Delsante G; Porru G; Salaffi F; Giuggioli D; Rossini M; Todoerti M; Bazzichi L; Govoni M; Gerli R; Raschetti R; Minisola G; Montecucco C; Todesco S;
Clin Exp Rheumatol; 2013; 31(6):857-63. PubMed ID: 23981363
[TBL] [Abstract][Full Text] [Related]
28. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis.
Kim JH; Choi IA
Int J Rheum Dis; 2021 Apr; 24(4):477-486. PubMed ID: 32969177
[TBL] [Abstract][Full Text] [Related]
30. Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials.
Xu Z; Xu P; Fan W; Yang G; Wang J; Cheng Q; Yu M
Exp Ther Med; 2017 Oct; 14(4):3491-3500. PubMed ID: 29042938
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
[TBL] [Abstract][Full Text] [Related]
32. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
[TBL] [Abstract][Full Text] [Related]
33. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
34. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K
J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803
[TBL] [Abstract][Full Text] [Related]
35. Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.
Huang TL; Hsiao FY; Chiang CK; Shen LJ; Huang CF
PLoS One; 2019; 14(5):e0215248. PubMed ID: 31112536
[TBL] [Abstract][Full Text] [Related]
36. Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER.
Carmona L; Gómez-Reino JJ;
Arthritis Res Ther; 2006; 8(3):R72. PubMed ID: 16620398
[TBL] [Abstract][Full Text] [Related]
37. Association of Unrecognized Myocardial Infarction With Long-term Outcomes in Community-Dwelling Older Adults: The ICELAND MI Study.
Acharya T; Aspelund T; Jonasson TF; Schelbert EB; Cao JJ; Sathya B; Dyke CK; Aletras AH; Sigurdsson S; Thorgeirsson G; Eiriksdottir G; Harris T; Launer LJ; Gudnason V; Arai AE
JAMA Cardiol; 2018 Nov; 3(11):1101-1106. PubMed ID: 30304454
[TBL] [Abstract][Full Text] [Related]
38. Backfill is a specific sign of axial spondyloarthritis seen on MRI.
Hu Z; Wang X; Qi J; Kong Q; Zhao M; Gu J
Joint Bone Spine; 2016 Mar; 83(2):179-83. PubMed ID: 26709251
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Vasodilator Stress Perfusion Cardiovascular Magnetic Resonance in Patients With Prior Myocardial Infarction.
Pezel T; Garot P; Kinnel M; Unterseeh T; Hovasse T; Champagne S; Landon V; Toupin S; Sanguineti F; Garot J
JACC Cardiovasc Imaging; 2021 Nov; 14(11):2138-2151. PubMed ID: 34147458
[TBL] [Abstract][Full Text] [Related]
40. Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.
Menegatti S; Bianchi E; Rogge L
Front Immunol; 2019; 10():382. PubMed ID: 30941119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
